Skip to main content
All lobbying filings

ORCHARD THERAPEUTICS NORTH AMERICA

Lobbying for ORCHARD THERAPEUTICS NORTH AMERICA · Health

 Filing 1st Quarter - Amendment
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $470,000.00 expenses · posted Apr 29, 2026

Official filing document

 Bills named in this filing 1
 Lobbying activity 2
Medicare/Medicaid

H.R. 7871: Medicaid Value-Based Payments for Patients (MVP) Act AKATCA and states' awareness of VBA's

Health Issues

Accelerating Kids' Access to Care Act and Pediatric Priority Review Voucher (Give Kids a Chance Act) FDA Policies: Rare Disease Gene Therapy Approvals Newborn Screening, including HRSA Appropriations & Fundings; RUSP Conditions

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem